Covid-19, Cost Benefit Analysis, New Zealand
Market Risk Premium, Historical Estimates
Saving Lives, Costs
CAPM, Beta, Firm Specific Risk
Market weight, Stocks, Betas, Portfolio theory, Nokia, Helsinki stock exchange
Beta, Portfolio, Market weight, Abnormal returns
Market risk premium, New Zealand, Siegel, Ibbotson-type estimate
Historical analysis, Equities, Government bonds, Yields, Inflation rate, New Zealand, CAPM
Risk free rate, Regulation, Corporate debt, Present Value, Equity
Lally, Risk Free rate, Regulatory term, Present Value
Officer model, Brennan-Lally model, Sharpe-Lintner-Mossin model, CAPM, Regulatory revenues
Beta, Industry weights
US, Social discount rate, Optimal portfolio, Assets
Expenditures, Fixed assets, Firm valuation, Cash flow
Land rent, Ground rental rate, Land value, Frequency of revision
Company valuation, Personal taxation, Dividends, Imputation, Capital Gains
Cost of capital, Capital charge process, SOEs, CAPM
Valuation model, Dividends, Discounting, Growth rate, Gordon-Shapiro
Regulation, Risk free rate, Output prices, Firms, Cost of Capital
Officer Model, Cost of Equity Capital, Regulation, CAPM, Australia, market risk premium
Market portfolio, Share portfolio, Ibbotson, Market risk premium, Miller-Modigliani
Market portfolio, Equity betas, Share portfolio, Leverage
Pension, Superannuation, New Zealand, Valuation
Cost of Capital, New Zealand, Foreign direct investment, Equity markets, Policy implications
Cost of equity, CAPM, Market portfolio, Share index, Bias, Factor coefficients
New Zealand, Accrual accounting, Asset revaluation, Capital charging, Output budgeting, Management
Volatility, Time series, Option Pricing, Non-Parametric, Max Likelihood estimation
